Olopatadine Hydrochloride Patent Expiration
Olopatadine Hydrochloride is Used for treating allergic conjunctivitis and relieving ocular itching associated with allergic conjunctivitis. It was first introduced by Alcon Laboratories Inc
Olopatadine Hydrochloride Patents
Given below is the list of patents protecting Olopatadine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Pataday Once Daily Relief | US8791154 | High concentration olopatadine ophthalmic composition | May 19, 2032 | Alcon Labs Inc |
| Pataday Once Daily Relief | US9533053 | High concentration olopatadine ophthalmic composition | May 19, 2032 | Alcon Labs Inc |
| Pataday Once Daily Relief |
US6995186 (Pediatric) | Olopatadine formulations for topical administration |
May 12, 2024
(Expired) | Alcon Labs Inc |
| Pataday Once Daily Relief | US6995186 | Olopatadine formulations for topical administration |
Nov 12, 2023
(Expired) | Alcon Labs Inc |
| Patanase |
US7977376 (Pediatric) | Olopatadine formulations for topical nasal administration |
Aug 02, 2023
(Expired) | Novartis |
| Patanase |
US8399508 (Pediatric) | Olopatadine formulations for topical nasal administration |
Mar 17, 2023
(Expired) | Novartis |
| Patanase | US7977376 | Olopatadine formulations for topical nasal administration |
Feb 02, 2023
(Expired) | Novartis |
| Pataday Once Daily Relief |
US7402609 (Pediatric) | Olopatadine formulations for topical administration |
Dec 19, 2022
(Expired) | Alcon Labs Inc |
| Patanase | US8399508 | Olopatadine formulations for topical nasal administration |
Sep 17, 2022
(Expired) | Novartis |
| Pataday Once Daily Relief | US7402609 | Olopatadine formulations for topical administration |
Jun 19, 2022
(Expired) | Alcon Labs Inc |
| Pataday Once Daily Relief |
US5641805 (Pediatric) | Topical ophthalmic formulations for treating allergic eye diseases |
Dec 06, 2015
(Expired) | Alcon Labs Inc |
| Pataday Twice Daily Relief |
US5641805 (Pediatric) | Topical ophthalmic formulations for treating allergic eye diseases |
Dec 06, 2015
(Expired) | Alcon Labs Inc |
| Pataday Once Daily Relief | US5641805 | Topical ophthalmic formulations for treating allergic eye diseases |
Jun 06, 2015
(Expired) | Alcon Labs Inc |
| Pataday Twice Daily Relief | US5641805 | Topical ophthalmic formulations for treating allergic eye diseases |
Jun 06, 2015
(Expired) | Alcon Labs Inc |
Olopatadine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Olopatadine Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Olopatadine Hydrochloride. The first generic version for Olopatadine Hydrochloride was by Apotex Inc and was approved on Oct 8, 2014. And the latest generic version is by Hikma Pharmaceuticals Usa Inc and was approved on Aug 19, 2020.
Given below is the list of companies who have filed for Olopatadine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.1% BASE | solution/drops | Over the counter | OPHTHALMIC | N/A | Dec 7, 2018 |
| EQ 0.2% BASE | solution/drops | Over the counter | OPHTHALMIC | N/A | Apr 29, 2019 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
2. AMNEAL
Amneal Pharmaceuticals Llc has filed for 1 generic for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.665MG/SPRAY
(reference standard) | spray, metered | Prescription | NASAL | AB | Jan 28, 2020 |
Manufacturing Plant Locations New
Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
3. APOTEX
Apotex Inc has filed for 2 different strengths of generic version for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.1% BASE | solution/drops | Over the counter | OPHTHALMIC | N/A | Dec 7, 2015 |
| EQ 0.2% BASE | solution/drops | Over the counter | OPHTHALMIC | N/A | Dec 5, 2017 |
Manufacturing Plant Locations New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||
| Canada |
| |||||||||||||
| India |
| |||||||||||||
4. APOTEX INC
Apotex Inc has filed for 1 generic for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Apotex Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.665MG/SPRAY | spray, metered | Prescription | NASAL | AB | Oct 8, 2014 |
Manufacturing Plant Locations New
Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| Canada |
| |||||||
5. BARR LABS INC
Barr Laboratories Inc has filed for 1 generic for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Barr Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.2% BASE | solution/drops | Over the counter | OPHTHALMIC | N/A | Jul 13, 2015 |
6. BAUSCH AND LOMB INC
Bausch And Lomb Inc has filed for 2 different strengths of generic version for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Bausch And Lomb Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.1% BASE | solution/drops | Discontinued | OPHTHALMIC | N/A | Jul 26, 2017 |
| EQ 0.2% BASE | solution/drops | Discontinued | OPHTHALMIC | N/A | Dec 5, 2017 |
7. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 2 different strengths of generic version for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.1% BASE | solution/drops | Over the counter | OPHTHALMIC | N/A | Dec 18, 2015 |
| EQ 0.2% BASE | solution/drops | Over the counter | OPHTHALMIC | N/A | Apr 4, 2019 |
Manufacturing Plant Locations New
Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| India |
| |||||||
8. FDC LTD
Fdc Ltd has filed for 1 generic for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Fdc Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.1% BASE | solution/drops | Discontinued | OPHTHALMIC | N/A | Sep 26, 2019 |
9. FLORIDA
Florida Pharmaceutical Products Llc has filed for 1 generic for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Florida.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.7% BASE | solution/drops | Discontinued | OPHTHALMIC | N/A | Feb 19, 2020 |
10. GLAND PHARMA LTD
Gland Pharma Ltd has filed for 2 different strengths of generic version for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.1% BASE | solution/drops | Over the counter | OPHTHALMIC | N/A | Aug 2, 2019 |
| EQ 0.2% BASE | solution/drops | Over the counter | OPHTHALMIC | N/A | May 20, 2020 |
11. GLENMARK PHARMS INC
Glenmark Pharmaceuticals Inc Usa has filed for 1 generic for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.1% BASE | solution/drops | Over the counter | OPHTHALMIC | N/A | Jun 28, 2017 |
12. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.665MG/SPRAY | spray, metered | Discontinued | NASAL | N/A | Aug 19, 2020 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| Portugal |
| |||||||||
| Jordan |
| |||||||||
13. PADAGIS ISRAEL
Padagis Israel Pharmaceuticals Ltd has filed for 1 generic for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Padagis Israel.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.665MG/SPRAY | spray, metered | Prescription | NASAL | AB | Jan 31, 2017 |
Manufacturing Plant Locations New
Padagis Israel's manufacturing plants are situated in 1 country - Israel. Given below are the details of these plant locations as well as the firm names of Padagis Israel as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| Israel |
| |||
14. RISING
Rising Pharma Holdings Inc has filed for 2 different strengths of generic version for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.1% BASE | solution/drops | Discontinued | OPHTHALMIC | N/A | Mar 21, 2018 |
| EQ 0.2% BASE | solution/drops | Discontinued | OPHTHALMIC | N/A | Jun 16, 2020 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||
| Mexico |
| |||||||||||||||||||
| India |
| |||||||||||||||||||
15. SCIEGEN PHARMS INC
Sciegen Pharmaceuticals Inc has filed for 2 different strengths of generic version for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.1% BASE | solution/drops | Discontinued | OPHTHALMIC | N/A | Jan 10, 2017 |
| EQ 0.2% BASE | solution/drops | Discontinued | OPHTHALMIC | N/A | Dec 5, 2017 |
16. SOMERSET THERAPS LLC
Somerset Therapeutics Llc has filed for 1 generic for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Somerset Theraps Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.1% BASE | solution/drops | Over the counter | OPHTHALMIC | N/A | Dec 7, 2015 |
17. USV
Usv Private Ltd has filed for 1 generic for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Usv.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.1% BASE | solution/drops | Over the counter | OPHTHALMIC | N/A | Dec 7, 2015 |
Manufacturing Plant Locations New
Usv's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Usv as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| India |
| |||||||
18. ZAMBON SPA
Zambon Spa has filed for 1 generic for Olopatadine Hydrochloride. Given below are the details of the strengths of this generic introduced by Zambon Spa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.1% BASE | solution/drops | Discontinued | OPHTHALMIC | N/A | Dec 7, 2015 |